Merck and Pfizer Going To Court Over Korea FTC Fines; Lilly And GSK Watch From The Sidelines

SEOUL - Merck, Sharp & Dohme Korea, Korea Otsuka Pharmaceuticals and Pfizer Korea are appealing the South Korea Fair Trade Commission decision to impose fines on the companies in January for unfair rebate provisions and other improper benefits to doctors and hospitals